MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Prevention of Recurrent Venous Thromboembolism (PREVENT)

Phase 3
Completed
Conditions
Cardiovascular Diseases
Peripheral Vascular Diseases
Heart Diseases
Thromboembolism
Vascular Diseases
Venous Thromboembolism
First Posted Date
1999-10-28
Last Posted Date
2016-03-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000614

Azithromycin and Coronary Events Study (ACES)

Phase 3
Completed
Conditions
Coronary Disease
Heart Diseases
Myocardial Infarction
Cardiovascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-11-06
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000617

Management of Patent Ductus in Premature Infants

Phase 3
Completed
Conditions
Cardiovascular Diseases
Defect, Congenital Heart
Ductus Arteriosus, Patent
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2013-12-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000494

Prevention of Coronary Aneurysms in Kawasaki Syndrome

Phase 2
Completed
Conditions
Coronary Aneurysm
Heart Diseases
Mucocutaneous Lymph Node Syndrome
Cardiovascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2013-12-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000520

Cholesterol-Lowering Atherosclerosis Study (CLAS)

Phase 3
Completed
Conditions
Cerebral Arteriosclerosis
Arterial Occlusive Diseases
Cardiovascular Diseases
Coronary Disease
Carotid Artery Diseases
Coronary Arteriosclerosis
Cerebrovascular Disorders
Heart Diseases
Myocardial Ischemia
Atherosclerosis
First Posted Date
1999-10-28
Last Posted Date
2013-12-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000599

Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial

Phase 3
Completed
Conditions
Respiratory Distress Syndrome
Lung Diseases
First Posted Date
1999-10-28
Last Posted Date
2013-12-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000570

Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up

Phase 2
Terminated
Conditions
Cardiovascular Diseases
Cerebrovascular Disorders
Heart Diseases
Vascular Diseases
Atherosclerosis
Carotid Artery Diseases
Intracranial Arteriosclerosis
First Posted Date
1999-10-28
Last Posted Date
2013-12-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000600

Beta-Blocker Evaluation in Survival Trial (BEST)

Phase 3
Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Heart Failure, Congestive
Heart Failure
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000560

Digitalis Investigation Group (DIG)

Phase 3
Completed
Conditions
Cardiovascular Diseases
Arrhythmia
Heart Diseases
Heart Failure, Congestive
Sinus Arrhythmia
Heart Failure
First Posted Date
1999-10-28
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000476

Dietary Patterns, Sodium Intake and Blood Pressure (DASH - Sodium)

Phase 2
Completed
Conditions
Hypertension
Vascular Diseases
Cardiovascular Diseases
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-07-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000608
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy